Filtrer vos résultats
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancerOncoImmunology, 2017, 6 (9), pp.e1339856. ⟨10.1080/2162402X.2017.1339856⟩
Article dans une revue
hal-01694057v1
|